SCHEMBL22985390

SCHEMBL22985390

N#Cc1cc(C(F)(F)F)ccc1-c1ccc(-n2c3ccccc3c3cc(C(F)(F)F)ccc32)c(-c2c(C#N)cccc2-n2c3ccccc3c3cc(C(F)(F)F)ccc32)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39
XDH P47989 1/20 0.34
KIF11 P52732 1/20 0.33
PTPN5 P54829 1/20 0.33
HRH1 P35367 1/20 0.32
HTR6 P50406 1/20 0.32
AR P10275 5/20 0.32
TSHR P16473 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GABRA1 P14867 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
CNR2 P34972 1/20 0.31
FFAR2 O15552 1/20 0.31
MC2R Q01718 1/20 0.31
PPARG P37231 2/20 0.31
PPARA Q07869 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985522 0.96 ALOX5AP (0.37) ALOX5APFEN1XDHKIF11PTPN5
SCHEMBL22985545 0.96 ALOX5AP (0.38) ALOX5APFEN1XDHKIF11PTPN5
SCHEMBL22985629 0.96 ALOX5AP (0.41) ALOX5APFEN1XDHPTPN5HRH1
SCHEMBL22985387 0.94 ALOX5AP (0.37) ALOX5APFEN1XDHKIF11PTPN5
SCHEMBL22985388 0.94 ALOX5AP (0.37) ALOX5APFEN1XDHKIF11PTPN5
SCHEMBL22985395 0.94 ALOX5AP (0.37) ALOX5APFEN1XDHKIF11PTPN5
SCHEMBL22985389 0.94 ALOX5AP (0.37) ALOX5APFEN1XDHKIF11PTPN5
SCHEMBL22985548 0.94 ALOX5AP (0.36) ALOX5APFEN1XDHKIF11PTPN5
SCHEMBL22985511 0.94 ALOX5AP (0.36) ALOX5APFEN1XDHKIF11PTPN5
SCHEMBL22985666 0.94 ALOX5AP (0.36) ALOX5APFEN1XDHKIF11PTPN5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 ALOX5AP 2567/4885FEN1 2939/4885XDH 1167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.